BACKGROUND: Modeling studies of the insulin-glucose relationship have mainly utilized parametric models, most notably the minimal model (MM) of glucose disappearance. This article presents results from the comparative analysis of the parametric MM and a nonparametric Laguerre based Volterra Model (LVM) applied to the analysis of insulin modified (IM) intravenous glucose tolerance test (IVGTT) data from a clinical study of gestational diabetes mellitus (GDM). METHODS: An IM IVGTT study was performed 8 to 10 weeks postpartum in 125 women who were diagnosed with GDM during their pregnancy [population at risk of developing diabetes (PRD)] and in 39 control women with normal pregnancies (control subjects). The measured plasma glucose and insulin from the IM IVGTT in each group were analyzed via a population analysis approach to estimate the insulin sensitivity parameter of the parametric MM. In the nonparametric LVM analysis, the glucose and insulin data were used to calculate the first-order kernel, from which a diagnostic scalar index representing the integrated effect of insulin on glucose was derived. RESULTS: Both the parametric MM and nonparametric LVM describe the glucose concentration data in each group with good fidelity, with an improved measured versus predicted r² value for the LVM of 0.99 versus 0.97 for the MM analysis in the PRD. However, application of the respective diagnostic indices of the two methods does result in a different classification of 20% of the individuals in the PRD. CONCLUSIONS: It was found that the data based nonparametric LVM revealed additional insights about the manner in which infused insulin affects blood glucose concentration.
BACKGROUND: Modeling studies of the insulin-glucose relationship have mainly utilized parametric models, most notably the minimal model (MM) of glucose disappearance. This article presents results from the comparative analysis of the parametric MM and a nonparametric Laguerre based Volterra Model (LVM) applied to the analysis of insulin modified (IM) intravenous glucose tolerance test (IVGTT) data from a clinical study of gestational diabetes mellitus (GDM). METHODS: An IM IVGTT study was performed 8 to 10 weeks postpartum in 125 women who were diagnosed with GDM during their pregnancy [population at risk of developing diabetes (PRD)] and in 39 control women with normal pregnancies (control subjects). The measured plasma glucose and insulin from the IM IVGTT in each group were analyzed via a population analysis approach to estimate the insulin sensitivity parameter of the parametric MM. In the nonparametric LVM analysis, the glucose and insulin data were used to calculate the first-order kernel, from which a diagnostic scalar index representing the integrated effect of insulin on glucose was derived. RESULTS: Both the parametric MM and nonparametric LVM describe the glucose concentration data in each group with good fidelity, with an improved measured versus predicted r² value for the LVM of 0.99 versus 0.97 for the MM analysis in the PRD. However, application of the respective diagnostic indices of the two methods does result in a different classification of 20% of the individuals in the PRD. CONCLUSIONS: It was found that the data based nonparametric LVM revealed additional insights about the manner in which infused insulin affects blood glucose concentration.
Authors: Mihalis G Markakis; Georgios D Mitsis; George P Papavassilopoulos; Petros A Ioannou; Vasilis Z Marmarelis Journal: Optim Control Appl Methods Date: 2011 Impact factor: 2.530
Authors: A Kautzky-Willer; K Thomaseth; B Ludvik; P Nowotny; D Rabensteiner; W Waldhäusl; G Pacini; R Prager Journal: Diabetes Date: 1997-04 Impact factor: 9.461
Authors: Christine Winzer; Oswald Wagner; Andreas Festa; Barbara Schneider; Michael Roden; Dagmar Bancher-Todesca; Giovanni Pacini; Tohru Funahashi; Alexandra Kautzky-Willer Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112
Authors: Micaela Morettini; Carlo Castriota; Christian Göbl; Alexandra Kautzky-Willer; Giovanni Pacini; Laura Burattini; Andrea Tura Journal: Diabetes Metab J Date: 2020-01-13 Impact factor: 5.376